Although it is possible that the skeletal impairment in the Opa3L122P mice relates to the specific mutation in this model, Costeff syndrome has been reported in humans with mutations in exon2 of Opa3 (19,23). The gene discussed is OPA3; the disease is 3-methylglutaconic aciduria type 3.